Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DBCG Proton Trial. Adjuvant Breast Proton Radiation Therapy for Early Breast Cancer Patients: The Skagen Trial 2, a Clinically Controlled Randomised Phase III Trial

NCT04291378 is registered in ClinicalTrials.gov with Danish Breast Cancer Cooperative Group as lead sponsor.

NCT NCT04291378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04291378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DBCG Proton Trial. Adjuvant Breast Proton Radiation Therapy for Early Breast Cancer Patients: The Skagen Trial 2, a Clinically Controlled Randomised Phase III Trial
Lead sponsor
Danish Breast Cancer Cooperative Group
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2020
Completion date
June 1, 2037
Enrollment
1,502 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

early breast cancer, radiation associated cardiac failure